In this note, we show revisions to our forecasts and our updated valuation of AVAX ahead of the company’s FY24 results (expected April 2025). AVAX’s H124 revenues and EBITDA were up 50.4% and 97.5% y-o-y, on the back of a raft of contract wins over the previous few years. The company has also guide

10 Mar 2025
Significant year-on-year growth expected

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Significant year-on-year growth expected
J&P-AVAX (AVAX:), 0 | Avax S.A. (AVAX:ATH), 0
- Published:
10 Mar 2025 -
Author:
Andy Murphy | Harry Kilby -
Pages:
4 -
In this note, we show revisions to our forecasts and our updated valuation of AVAX ahead of the company’s FY24 results (expected April 2025). AVAX’s H124 revenues and EBITDA were up 50.4% and 97.5% y-o-y, on the back of a raft of contract wins over the previous few years. The company has also guide